There were two downregulated transcription factors (BARX2 and CDX2), a glutathione regulating enzyme (GGT6) and a serine protease that correlates with improved survival in ovarian cancer (PRSS16) [37]. This evidence concerns the gene PRSS16 and ovarian carcinoma.